Clinical Trial Update: Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

View source ↗

Summary

Clinical trial update for a study evaluating renal mass biopsy, PEER, and 99mTc-sestamibi SPECT/CT in patients with localized renal tumors; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Neoplasm

Snippet

Sponsor: Loyola University | Conditions: Kidney Tumor, Renal Benign Neoplasm | Status: RECRUITING